RedHill Biopharma (RDHL) Other financing activities (2020)
RedHill Biopharma (RDHL) reported Other financing activities of $4.0 million for Q3 2020, up 120.0% quarter-over-quarter from -$20.0 million in Q1 2020.
RedHill Biopharma (RDHL) Other financing activities (2020) Analysis & Trends
RedHill Biopharma (RDHL) has 1 years of Other financing activities data on file, last reported at $4.0 million in Q3 2020.
- Other financing activities for Q3 2020 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was -$16.0 million (changed N/A YoY), and the FY2024 annual result was $474000.0, down 93.93% from the prior year.
- Other financing activities grew to $4.0 million in Q3 2020 per RDHL's latest filing, from -$20.0 million in the prior quarter.
- Over five years, Other financing activities peaked at $4.0 million in Q3 2020 and troughed at -$20.0 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 4.00 Mn |
| Sep 30, 2020 | 4.00 Mn |
| Mar 31, 2020 | -20.00 Mn |
| Mar 31, 2020 | -20.00 Mn |